Learn more

BERLIN CHEMIE AG

Overview
  • Total Patents
    249
  • GoodIP Patent Rank
    18,659
  • Filing trend
    ⇧ 1650.0%
About

BERLIN CHEMIE AG has a total of 249 patent applications. It increased the IP activity by 1650.0%. Its first patent ever was published in 1985. It filed its patents most often in German Democratic Republic, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NORDIC NANOVECTOR ASA, ADC THERAPEUTICS S RL and ADC THERAPEUTICS SARL.

Patent filings per year

Chart showing BERLIN CHEMIE AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pellacani Andrea 45
#2 Schmitz Reinhard 45
#3 Binaschi Monica 45
#4 Wihsmann Marc 41
#5 Stubinski Bettina 36
#6 Bigioni Mario 28
#7 Merlino Giuseppe 28
#8 Simonelli Cecilia 25
#9 Maggi Carlo Alberto 24
#10 Manzini Stefano 23

Latest patents

Publication Filing date Title
GB201809746D0 Pharmaceutical combinations
GB201806084D0 Antibodies
IT201800004082A1 ANTI-CANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
WO2018141938A1 Oral thyroid therapeutic agent
WO2019120545A1 Holder system for a plastic infuser bottle, plastic infuser bottle and method for producing a plastic infuser bottle with a holder system
DE102017122807A1 Oral thyroid therapy
UA119047C2 Conjugated antibodies against ly75 for the treatment of cancer
TW201412741A Process for the preparation of pemetrexed and lysine salt thereof
CN101406460A Euthyrox tablet
WO2007104583A1 Accurately divisible tablet
CN101229187A Simethicone emulsion and preparing method thereof
EP1772395A1 Protective packaging for pharmaceutical products
DE102005046769A1 Ophthalmic composition, useful to treat eye diseases e.g. herpes simplex virus-epithelial keratitis, comprises brivudine, auxiliary materials and film former such as polyvinyl pyrrolidone, polyvinyl alcohol or polyacrylate
TW200509897A Stabilized topical formulations containing ketoprofen
EP1488787A1 Topical stabilized formulations containing ketoprofen
MY136633A Stabilized brivudine topical formulations
DE10136615A1 thyroid therapeutics
BR0102717A Brivudine single daily dosage pharmaceutical composition
MXPA01005658A Brivudin-containing daily pharmaceutical composition.
RO121585B1 Use of brivudine in the treatment of herpes-zoster type infections or post-herpetic neuralgia